To validate polysomnographic markers (sleep latency and sleep-onset REM periods [SOREMPs] at the Multiple Sleep Latency Test [MSLT] and nocturnal polysomnography [PSG]) for pediatric narcolepsy type 1 (NT1) against CSF hypocretin-1 (hcrt-1) deficiency and presence of cataplexy, as no criteria are currently validated in children.
Pizza, F., Barateau, L., Jaussent, I., Vandi, S., Antelmi, E., Mignot, E., et al. (2019). Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1. NEUROLOGY, 93(11), e1034-e1044 [10.1212/WNL.0000000000008094].
Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1
Pizza, Fabio;Vandi, Stefano;Antelmi, Elena;Plazzi, Giuseppe
2019
Abstract
To validate polysomnographic markers (sleep latency and sleep-onset REM periods [SOREMPs] at the Multiple Sleep Latency Test [MSLT] and nocturnal polysomnography [PSG]) for pediatric narcolepsy type 1 (NT1) against CSF hypocretin-1 (hcrt-1) deficiency and presence of cataplexy, as no criteria are currently validated in children.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



